Kobayashi Pharmaceutical Co., Ltd.

TSE:4967 Stock Report

Market Cap: JP¥425.9b

Kobayashi Pharmaceutical Future Growth

Future criteria checks 2/6

Kobayashi Pharmaceutical is forecast to grow earnings and revenue by 19% and 3.7% per annum respectively. EPS is expected to grow by 19.1% per annum. Return on equity is forecast to be 8.1% in 3 years.

Key information

19.0%

Earnings growth rate

19.1%

EPS growth rate

Personal Products earnings growth19.7%
Revenue growth rate3.7%
Future return on equity8.1%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Kobayashi Pharmaceutical's (TSE:4967) Soft Earnings Are Actually Better Than They Appear

Aug 21
Kobayashi Pharmaceutical's (TSE:4967) Soft Earnings Are Actually Better Than They Appear

Getting In Cheap On Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) Is Unlikely

Aug 04
Getting In Cheap On Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) Is Unlikely

Investor Optimism Abounds Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) But Growth Is Lacking

Apr 21
Investor Optimism Abounds Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) But Growth Is Lacking

Estimating The Fair Value Of Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)

Apr 03
Estimating The Fair Value Of Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)

Investors Met With Slowing Returns on Capital At Kobayashi Pharmaceutical (TSE:4967)

Feb 27
Investors Met With Slowing Returns on Capital At Kobayashi Pharmaceutical (TSE:4967)

Earnings and Revenue Growth Forecasts

TSE:4967 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026183,42618,50716,512N/A8
12/31/2025175,95217,4209,934N/A8
12/31/2024167,70710,11612,536N/A6
9/30/2024168,79910,184N/AN/AN/A
6/30/2024172,96613,910-10,82416,636N/A
3/31/2024176,47317,706N/AN/AN/A
12/31/2023173,45520,3384,79118,360N/A
9/30/2023171,09421,020N/AN/AN/A
6/30/2023168,61920,1861,42920,341N/A
3/31/2023167,07920,157N/AN/AN/A
12/31/2022166,25820,02215,68531,914N/A
9/30/2022161,87319,332N/AN/AN/A
6/30/2022159,46419,53423,86431,465N/A
3/31/2022157,62919,560N/AN/AN/A
12/31/2021155,25219,71518,23422,419N/A
9/30/2021153,12318,830N/AN/AN/A
6/30/2021151,38618,86818,00321,790N/A
3/31/2021148,87219,091N/AN/AN/A
12/31/2020150,51419,20519,83723,986N/A
9/30/2020155,31219,152N/AN/AN/A
6/30/2020160,60219,15520,13324,786N/A
3/31/2020166,22819,198N/AN/AN/A
12/31/2019168,05219,13915,28520,089N/A
9/30/2019169,50019,259N/AN/AN/A
6/30/2019168,43118,59616,73520,861N/A
3/31/2019167,49917,885N/AN/AN/A
12/31/2018167,47918,02316,30620,007N/A
9/30/2018164,87618,132N/AN/AN/A
6/30/2018162,13216,455N/A19,577N/A
3/31/2018159,72716,229N/AN/AN/A
12/31/2017156,76115,863N/A22,350N/A
12/31/2016152,65415,333N/A21,463N/A
9/30/2016148,00815,561N/A18,058N/A
6/30/2016144,00715,801N/AN/AN/A
3/31/2016137,21113,466N/A14,329N/A
12/31/2015135,79814,230N/AN/AN/A
9/30/2015133,38513,008N/A15,474N/A
6/30/2015131,14412,915N/AN/AN/A
3/31/2015128,34412,448N/A15,445N/A
12/31/2014128,72112,730N/AN/AN/A
9/30/2014127,57411,808N/A14,931N/A
6/30/2014127,25611,760N/AN/AN/A
3/31/2014127,29312,307N/A13,513N/A
12/31/2013122,43010,819N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4967's forecast earnings growth (19% per year) is above the savings rate (0.3%).

Earnings vs Market: 4967's earnings (19% per year) are forecast to grow faster than the JP market (7.9% per year).

High Growth Earnings: 4967's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4967's revenue (3.7% per year) is forecast to grow slower than the JP market (4.2% per year).

High Growth Revenue: 4967's revenue (3.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4967's Return on Equity is forecast to be low in 3 years time (8.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y